148 related articles for article (PubMed ID: 9200284)
1. Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit.
Song CW; UM SH; Kim CD; Ryu HS; Hyun JH; Choe JG
Scand J Gastroenterol; 1997 Jun; 32(6):541-6. PubMed ID: 9200284
[TBL] [Abstract][Full Text] [Related]
2. Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis.
Wang SJ; La JL; Chen DY; Chen YH; Hsieh TY; Lin WY
Clin Rheumatol; 2002 Feb; 21(1):43-5. PubMed ID: 11954884
[TBL] [Abstract][Full Text] [Related]
3. [Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma].
Wehrmann T; Caspary WF
Klin Wochenschr; 1990 Jun; 68(12):602-7. PubMed ID: 2198381
[TBL] [Abstract][Full Text] [Related]
4. Cisapride stimulates human esophageal motility.
Katschinski M; Wank U; Ducree M; Schirra J; Arnold R
Digestion; 1995; 56(2):153-8. PubMed ID: 7750669
[TBL] [Abstract][Full Text] [Related]
5. Hot water swallows improve symptoms and accelerate esophageal clearance in esophageal motility disorders.
Triadafilopoulos G; Tsang HP; Segall GM
J Clin Gastroenterol; 1998 Jun; 26(4):239-44. PubMed ID: 9649001
[TBL] [Abstract][Full Text] [Related]
6. Use of radioisotopic esophageal transit in the assessment of patients with symptoms of reflux and non-specific esophageal motor disorders.
Iascone C; Di Giulio E; Maffi C; Ruperto M
Dis Esophagus; 2004; 17(3):218-22. PubMed ID: 15361094
[TBL] [Abstract][Full Text] [Related]
7. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis.
Horowitz M; Maddern GJ; Maddox A; Wishart J; Chatterton BE; Shearman DJ
Gastroenterology; 1987 Aug; 93(2):311-5. PubMed ID: 3596167
[TBL] [Abstract][Full Text] [Related]
8. Cisapride in pediatric gastroesophageal reflux.
Scott RB; Ferreira C; Smith L; Jones AB; Machida H; Lohoues MJ; Roy CC
J Pediatr Gastroenterol Nutr; 1997 Nov; 25(5):499-506. PubMed ID: 9360203
[TBL] [Abstract][Full Text] [Related]
9. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease.
Holloway RH; Penagini R; Schoeman MN; Dent J
Am J Gastroenterol; 1999 Mar; 94(3):799-803. PubMed ID: 10086669
[TBL] [Abstract][Full Text] [Related]
10. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study.
Paterson WG; Wang H; Beck IT
Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196
[TBL] [Abstract][Full Text] [Related]
11. Effects of cisapride on distal esophageal motility in humans.
Corazziari E; Bontempo I; Anzini F
Dig Dis Sci; 1989 Oct; 34(10):1600-5. PubMed ID: 2791812
[TBL] [Abstract][Full Text] [Related]
12. Relationship of radionuclide liquid bolus transport and esophageal manometry.
Richter JE; Blackwell JN; Wu WC; Johns DN; Cowan RJ; Castell DO
J Lab Clin Med; 1987 Feb; 109(2):217-24. PubMed ID: 3805872
[TBL] [Abstract][Full Text] [Related]
13. Relationship between esophageal motility and transit in patients with type I diabetes mellitus.
Holloway RH; Tippett MD; Horowitz M; Maddox AF; Moten J; Russo A
Am J Gastroenterol; 1999 Nov; 94(11):3150-7. PubMed ID: 10566706
[TBL] [Abstract][Full Text] [Related]
14. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers.
Cho YK; Choi MG; Han HW; Park JM; Oh JH; Jeong JJ; Cho YS; Lee IS; Kim SW; Choi KY; Chung IS
J Clin Gastroenterol; 2006 Apr; 40(4):286-92. PubMed ID: 16633098
[TBL] [Abstract][Full Text] [Related]
15. Cisapride in the treatment of globus hystericus.
Leelamanit V; Geater A; Ovartlarnporn T
Adv Otorhinolaryngol; 1997; 51():112-24. PubMed ID: 9017080
[No Abstract] [Full Text] [Related]
16. Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome.
Noor N; Small PK; Loudon MA; Hau C; Campbell FC
Scand J Gastroenterol; 1998 Jun; 33(6):605-11. PubMed ID: 9669632
[TBL] [Abstract][Full Text] [Related]
17. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
[TBL] [Abstract][Full Text] [Related]
18. Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon.
Bestetti A; Carola F; Conciato L; Marasini B; Tarolo GL
J Nucl Med; 1999 Jan; 40(1):77-84. PubMed ID: 9935061
[TBL] [Abstract][Full Text] [Related]
19. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis.
Richards RD; Valenzuela GA; Davenport KG; Fisher KL; McCallum RW
Dig Dis Sci; 1993 May; 38(5):811-6. PubMed ID: 8482178
[TBL] [Abstract][Full Text] [Related]
20. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
